Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Shaw

Showing results (71-80 of 229) with videos related to

Pageof 23
Sort By:
The Surgical Clinics of North America|June 1, 1986
Indications for liver transplantation in the cyclosporine eraR D Gordon, B W Shaw, S Iwatsuki, et al.
Seminars in Liver Disease|November 1, 1985
Immunosuppression and other nonsurgical factors in the improved results of liver transplantationT E Starzl, S Iwatsuki, B W Shaw, et al.
The American Journal of Gastroenterology|August 1, 1990
Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplantR S Markin, R P Wood, B W Shaw, et al.
Surgery, Gynecology & Obstetrics|October 1, 1983
Cadaveric renal transplantation under cyclosporine-steroid therapyJ T Rosenthal, T R Hakala, S Iwatsuki, et al.
American Journal of Surgery|January 11, 1991
Vascular complications after orthotopic liver transplantationA N Langnas, W Marujo, R J Stratta, et al.
Surgery, Gynecology & Obstetrics|June 1, 1982
Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroidsT E Starzl, T R Hakala, J T Rosenthal, et al.
American Journal of Surgery|December 1, 1988
Complications requiring operative intervention after orthotopic liver transplantationR P Wood, L K Rosenlof, B W Shaw, et al.
Transplantation|December 1, 1985
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine eraA G Tzakis, R D Gordon, B W Shaw, et al.
Transplantation Proceedings|September 21, 2000
Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipientsD L Sudan, S Kaufman, S Horslen, et al.
Lancet (London, England)|June 24, 1995
Immunosuppressive drugs and hypertrophic cardiomyopathyA Dhawan, D R Mack, A N Langnas, et al.
Pageof 23

Showing results (71-80 of 229) with videos related to

Sort By:
Pageof 23
The Surgical Clinics of North America|June 1, 1986
Indications for liver transplantation in the cyclosporine eraR D Gordon, B W Shaw, S Iwatsuki, et al.
Seminars in Liver Disease|November 1, 1985
Immunosuppression and other nonsurgical factors in the improved results of liver transplantationT E Starzl, S Iwatsuki, B W Shaw, et al.
The American Journal of Gastroenterology|August 1, 1990
Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplantR S Markin, R P Wood, B W Shaw, et al.
Surgery, Gynecology & Obstetrics|October 1, 1983
Cadaveric renal transplantation under cyclosporine-steroid therapyJ T Rosenthal, T R Hakala, S Iwatsuki, et al.
American Journal of Surgery|January 11, 1991
Vascular complications after orthotopic liver transplantationA N Langnas, W Marujo, R J Stratta, et al.
Surgery, Gynecology & Obstetrics|June 1, 1982
Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroidsT E Starzl, T R Hakala, J T Rosenthal, et al.
American Journal of Surgery|December 1, 1988
Complications requiring operative intervention after orthotopic liver transplantationR P Wood, L K Rosenlof, B W Shaw, et al.
Transplantation|December 1, 1985
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine eraA G Tzakis, R D Gordon, B W Shaw, et al.
Transplantation Proceedings|September 21, 2000
Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipientsD L Sudan, S Kaufman, S Horslen, et al.
Lancet (London, England)|June 24, 1995
Immunosuppressive drugs and hypertrophic cardiomyopathyA Dhawan, D R Mack, A N Langnas, et al.
Pageof 23